P.305 The GABAA receptor positive allosteric modulator zuranolone in major depressive disorder: a double-blind, randomized, placebo-controlled phase 3 trial
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI